Can capital unlock the longevity economy?

As populations age and healthcare shifts from treating disease to extending healthy lifespans, longevity is emerging as one of the world’s fastest-growing investment themes. No longer confined to biotech laboratories, it now spans artificial intelligence, precision medicine, preventive healthcare, insurance, real estate, financial services and consumer wellness. Yet despite growing scientific progress, the sector faces a major obstacle: capital. Global investment in longevity has accelerated over the past decade, attracting venture capital, institutional investors and corporate funding.